Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Maxwell Biosciences
company
About
MaxWell Biosciences is biotechnology for optimizing cognitive performance and health span.
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $10.80M
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Maxwell Biosciences is a preclinical stage drug platform company actively developing an entirely new CLAROMER™ biotechnology platform which creates low molecular weight compounds which mimic peptides and are functionally distinct from macromolecules due to the ease of penetrating membranes.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$10.80M
Maxwell Biosciences has raised a total of
$10.80M
in funding over 2 rounds. Their latest funding was raised on
Mar 10, 2022 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 10, 2022 | Seed | $10.80M | 4 |
DecentraNet
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
4
Maxwell Biosciences is funded by 4 investors.
DecentraNet
and Joseph Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
DecentraNet
|
Yes | Seed |
|
|
— | Seed |
|
|
— | Seed |
Keiretsu Forum
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
